Effect of Three-Dimensional Lemon Video on Thirst Perception and Dehydration-Related Discomfort

August 19, 2025 updated by: Serpil SU, Necmettin Erbakan University

Effect of Three-Dimensional Lemon Video on Thirst Perception and Dehydration-Related Discomfort in Intensive Care Unit Patients Undergoing Colorectal Surgery: Randomized Controlled Study

This study will be conducted to investigate the effects of a three-dimensional lemon video shown to intensive care patients undergoing colorectal surgery on thirst perception and thirst-related discomfort. The study will be conducted as a randomized controlled, single-blind experimental design. The universe of this study, which will be conducted in the General Surgery Intensive Care Unit of the Necmettin Erbakan University Medical Faculty Hospital, will consist of volunteer patients who will be admitted to the intensive care unit. The sample of the study will consist of 70 patients. In the study, patients will be divided into two groups as virtual reality glasses and control groups. The virtual reality glasses group will be shown a three-dimensional lemon video. Standard care will be provided to patients in the control group. Patients will be assigned to the groups using the block randomization method. Randomization will be performed using a random number table in a computer environment (www.random.org). Research data will be collected using the Descriptive Characteristics Form, Numerical Rating Scale, and Surgical Period Thirst-Related Discomfort Scale (CDSBRÖ). Ethics committee approval and institutional permission will be obtained before collecting research data. Appropriate statistical tests will be used in the evaluation of the data.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
70

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • Turkey (Türkiye)
    • Konya
      • Konya, Konya, Turkey (Türkiye), 42040
        • Necmettin Erbakan Üniversity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients between the ages of 18-65,
  • Those who have undergone colorectal surgery,
  • Those who are oriented to time and place,
  • Those who are literate,
  • Those who have been admitted to the general surgery intensive care unit,
  • Those who are being monitored in the postoperative period,
  • Those who volunteer to participate in the study,
  • Those who can communicate verbally,
  • Those who are open to communication and cooperation,
  • Those who do not have visual and auditory impairments,
  • Those who do not use glasses or have no visual impairments,
  • Those who do not have cognitive-psychological disorders,
  • Those who are not diagnosed with renal failure,
  • Those who do not have oral intake according to the physician's order,
  • Those who are not connected to a mechanical ventilator will be included in the study.

Exclusion Criteria:

  • Patients who have undergone a second surgical procedure during their hospitalization,
  • Patients who have open wounds on their mouth or lips,
  • Patients who have been diagnosed with migraine or vertigo,
  • Patients who have nausea and vomiting will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
No Intervention: Control
Experimental: Three-dimensional video
Other: Three-dimensional video
Patients who meet the criteria for inclusion in the study will be randomly assigned to intervention and control groups. The intervention group will be shown a 3D lemon video with virtual reality glasses. The video will be created by a company that shoots 3D videos. Opinions of three experts will be obtained for the suitability of the video. The video will be shown to patients for 5 minutes. In order to control the effects that may arise from the practitioner during the study, the virtual reality glasses application will be applied to all patients by the same clinic nurse. The control group will not receive any intervention and will receive standard care. Data collection forms will be given to the patient by the researcher and will be collected after the patient fills them out.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Numerical Rating Scale
Time Frame: The 1st measurement will be made immediately before watching the 3D video, the 2nd measurement will be made within 1 minute after watching the 3D video, and the 3rd measurement will be made 30 minutes after watching the 3D video.
It will be used to assess the intensity of thirst perception. This scale has numerical values between 0-10 points and the individual is shown the scale and asked to choose the number that best describes thirst. It consists of a horizontal line that starts with the expression "0" or "I'm not thirsty at all" and ends with the expression "10" or "I'm very thirsty".
The 1st measurement will be made immediately before watching the 3D video, the 2nd measurement will be made within 1 minute after watching the 3D video, and the 3rd measurement will be made 30 minutes after watching the 3D video.
Perioperative Thirst Discomfort Scale
Time Frame: The 1st measurement will be made immediately before watching the 3D video, the 2nd measurement will be made within 1 minute after watching the 3D video, and the 3rd measurement will be made 30 minutes after watching the 3D video.
The scale is a 3-point Likert-type scale consisting of 7 items including dry mouth, dry lips, swollen tongue, saliva density, dry throat, bad taste in the mouth and desire to drink water. Rating is done as; It did not bother (0), It bothered a little (1) and It bothered a lot (2). The scale has no sub-dimensions. The lowest score from the original scale total is 0 and the highest is 14. The expression "Skewered slice" from the scale items was removed from the Turkish scale because it had a low factor load. The lowest score from the scale total is 0 and the highest is 12. Higher scores indicate more thirst.
The 1st measurement will be made immediately before watching the 3D video, the 2nd measurement will be made within 1 minute after watching the 3D video, and the 3rd measurement will be made 30 minutes after watching the 3D video.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Necmettin Erbakan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
February 25, 2025

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
June 20, 2025

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 20, 2025

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 23, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 23, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 29, 2025

Study Record Updates

Last Update Posted (Estimated)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 26, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 19, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • NecErUniveristy

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings